Michigan Attorney General Bill Schuette on Wednesday charged former USA Gymnastics and Michigan State University sports physician Lawrence G. Nassar with an additional 22 criminal counts tied to sexually abusing young female athletes.
President Donald Trump on Wednesday revoked an Obama administration guidance requiring public schools to allow transgender students to use bathrooms and other facilities that match their gender identity, just weeks before the U.S. Supreme Court prepares to hear arguments on another trans rights case.
Retail developer Jeff Sutton has reportedly raised $233 million through a bond sale on the Tel Aviv Stock Exchange, Tenet Healthcare is said to have bought a Florida hospital from HCP and Compass is said to be taking another 25,000 square feet on Fifth Avenue in New York.
The Cleveland Clinic Foundation on Tuesday continued its push to block True Health Diagnostics LLC from using a test for cardiovascular disease that the foundation discovered, claiming in Virginia federal court that True Health infringed one of its patents.
The former general counsel of retail pharmacy chain Rite Aid Corp. told the Delaware Supreme Court on Wednesday that his appeals of criminal convictions related to a $1.6 billion accounting scandal should extend the time during which he can seek repayment of his legal costs from the company.
The District of Columbia federal judge who preliminarily enjoined Anthem and Cigna’s proposed $54 billion merger on Tuesday released the redacted opinion detailing her decision. Here, Law360 shares three insights gleaned by experts from U.S. District Judge Amy B. Jackson’s analysis.
The White House gave its first concrete indication of the timeline and process for overhauling tax laws when press secretary Sean Spicer said on Wednesday that legislative changes could be forthcoming for the 2018 fiscal year.
A Massachusetts man charged with murder for his alleged role in the deadly 2012 meningitis outbreak grossed about $10 million over the 14 years his pharmacy was in business, with more than another $9 million going to his wife, according to evidence presented at his trial Wednesday.
A district court order requiring the U.S. Department of Health and Human Services to eliminate its 650,000-claim backlog of Medicare billing appeals by 2021 will improperly force the agency to pay claims regardless of merit, HHS told the D.C. Circuit on Tuesday.
A former Cedars-Sinai Medical Center employee has accused the hospital in a potential class action in California state court of withholding wages, not paying overtime, forcing employees to work during breaks and other wage-and-hour violations.
A now-closed Theranos Inc. laboratory in Arizona was hit with sanctions — including the yanking of its testing license — last month after a fall inspection turned up quality control problems, the second time one of the company’s labs has been penalized, according to a news report Wednesday.
The U.S. Consumer Product Safety Commission and the Natural Resources Defense Council have reached an agreement in principle for the federal agency to ban from children’s products five chemicals that may cause reproductive harm — more than two years after the CPSC was supposed to promulgate the rules, attorneys told a federal judge in New York Wednesday.
Baxter International Inc. and Hospira Inc. have each asked an Illinois federal court to dismiss an Alabama health care provider’s proposed antitrust class action alleging they conspired to fix the price of intravenous saline solution by using recalls to stage a shortage, with the former calling the allegations “pure fantasy.”
A federal judge on Tuesday barred the state of Texas from pulling Medicaid funds from Planned Parenthood-affiliated clinics, saying the secretly recorded videos the Lone Star State held up as evidence that the clinics were profiting from selling aborted fetal tissue did not actually support the state's claims.
The closely watched talc trial against Johnson & Johnson continued Tuesday with a grueling cross-examination of a Harvard epidemiologist who was asked why, if cancer survivor Nora Daniels was so interested in pinpointing the cause of her ovarian cancer, she has avoided a key genetic test.
A group of psychologists accused a Sidley Austin LLP attorney of crafting a report for the American Psychological Association that unfairly laid the blame on them for interrogation tactics used by the U.S. military after the 9/11 attacks, saying in an Ohio suit that he ignored evidence and bolstered a story by the doctors’ critics.
A D.C. federal judge on Tuesday granted a portion of a request by consumers suing insurer Anthem Inc. over its massive 2015 data breach for access to documents stemming from a government audit of the insurer’s systems in 2013, but found that some of the sought-after material was protected.
A Texas appellate court on Friday gave the Texas Association of Acupuncture and Oriental Medicine another shot at challenging the validity of two provisions in the Texas Board of Chiropractic Examiners administrative rules that it believes are invalid because they allow chiropractors to practice acupuncture.
A North Carolina federal judge on Monday threw out a former doctor’s antitrust suit against the state medical board and its members alleging they conspired to get him out of the Lyme disease treatment market, ruling that they’re immune from such a suit.
The U.S. Supreme Court declined Tuesday to take up the Czech Republic's challenge to a D.C. Circuit decision reviving a medical technology company's bid to enforce a more than $325 million arbitral award against the Central European nation, which had allegedly caused the collapse of the company's business there.
Detractors of litigation funding have strained to characterize a recent decision from a California federal court as significant headway in their crusade against the litigation funding industry. However, in truth, this is a victory for both the industry and those in need of capital to bring meritorious claims against wrongdoers in an often prohibitively expensive legal system, say Matthew Harrison and Priya G. Pai of Bentham IMF.
Not surprisingly, many different views emerged at this year's J.P. Morgan Healthcare Conference on the future state of the Affordable Care Act and what it would mean for investors. After a long and seemingly endless cycle of election analysis, we’re happy to report some deal trends and predictions of our own, say attorneys with McGuireWoods LLP.
Several areas of civil litigation appear poised for growth this year, including securities class action activity, which could outpace even the significant 2016 levels, and trade secret litigation, which could see further growth in the coming year under the Defend Trade Secrets Act. Meanwhile, as companies increasingly face the specter of data breaches, several developments in 2017 could bring greater clarity to this area of the law... (continued)
Marijuana cultivation suffers from the same pest and disease pressure as any large commercial greenhouse operation. However, the circumstance unique to this setting is that any use of a pesticide in the cultivation of marijuana is a violation of federal law, says Telisport Putsavage of Putsavage PLLC.
The European Union's General Data Protection Regulation will considerably increase the sanctions and penalties that can be imposed on organizations that breach its requirements. The implications for organizations operating in the life sciences and health care sectors are likely to be particularly far-reaching, say attorneys with Ropes & Gray LLP.
Fred Korematsu’s U.S. Supreme Court case challenging President Franklin Roosevelt’s executive order that led to the incarceration of approximately 120,000 people of Japanese ancestry may sound like ancient history. However, Feb. 19 marks the 75th anniversary of the order's signing, and that it’s celebrating its diamond anniversary now is breathtaking timing, says Randy Maniloff of White and Williams LLP.
Although Health Republic's liquidation is a matter of considerable public interest, the process has been far from transparent. Last fall, the National Association of Insurance Commissioners' discussion of consumer operated and oriented plans was closed to the public, in potential violation of the NAIC's policy statement on open meetings, says James Veach of Mound Cotton Wollan & Greengrass LLP.
While U.S. Supreme Court nominee Judge Neil Gorsuch has participated in only a few appeals of False Claims Act cases, his views suggest that companies and individuals subjected to FCA litigation based on disputed interpretations of agency regulations may find a sympathetic ear, say Scott Stein and Meredith Toole Reiter of Sidley Austin LLP.
General counsels face the challenging task of understanding how companies can navigate the rules surrounding uses of artificial intelligence. To get smart on AI, general counsels must ask the right questions about areas such as human resources, intellectual property, liability and insurance, say Bruce Heiman and Elana Reman of K&L Gates LLP.
Recent years have seen a surge of constitutional challenges to public unions’ right to require nonmembers to pay agency fees as a condition of continued employment. An evenly divided U.S. Supreme Court failed to resolve the issue in Friedrichs v. California Teachers Association, but new lawsuits are working their way through the federal courts and could reach the Supreme Court as early as next term, say attorneys with Ballard Spahr LLP.